Hepatitis A virus: Host interactions, molecular epidemiology and evolution

Infection, Genetics and Evolution

Volumn 21, Issue , 2014, Pages 227-243

  Vaughan, Gilberto ^a   Goncalves Rossi, Livia Maria ^a   Forbi, Joseph C ^a   de Paula, Vanessa S ^b   Purdy, Michael A ^a   Xia, Guoliang ^a   Khudyakov, Yury E ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Genetic relatedness; Genotype; Hepatitis A virus; Host factors; Molecular epidemiology; Molecular evolution

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CYTOCHROME P450 2E1; GAMMA INTERFERON; HEPATITIS A VACCINE; HLA DRB1 ANTIGEN; INITIATION FACTOR 4E; INITIATION FACTOR 4G; PATTERN RECOGNITION RECEPTOR; XRCC1 PROTEIN; VIRUS RNA;

CODON USAGE; DISEASE SURVEILLANCE; ENDEMIC DISEASE; EVOLUTION; FOOD CONTAMINATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENETIC RECOMBINATION; GENETIC SELECTION; GENETIC VARIABILITY; GENOTYPE; GEOGRAPHY; HAPLOTYPE; HEPATITIS A; HEPATITIS A VIRUS; HUMAN; IMMUNE RESPONSE; INFECTION PREVENTION; INFECTION SENSITIVITY; INNATE IMMUNITY; INTRAVENOUS DRUG ABUSE; MEN WHO HAVE SEX WITH MEN; MOLECULAR EPIDEMIOLOGY; MOLECULAR MECHANICS; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PHYLOGENY; POPULATION DYNAMICS; POPULATION GROWTH; PRIORITY JOURNAL; REVIEW; SEXUAL TRANSMISSION; STRAIN IDENTIFICATION; VIROGENESIS; VIRUS CELL INTERACTION; VIRUS GENOME; VIRUS PARTICLE; VIRUS STRAIN; VIRUS TRANSMISSION; WATER CONTAMINATION; ANIMAL; CLASSIFICATION; DISEASE OUTBREAKS; GENETICS; HIGH THROUGHPUT SEQUENCING; HOST PATHOGEN INTERACTION; PHYLOGEOGRAPHY; TRANSMISSION; VIROLOGY;

HEPATITIS A VIRUS;

ANIMALS; DISEASE OUTBREAKS; GENETIC VARIATION; HEPATITIS A; HEPATITIS A VIRUS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HOST-PATHOGEN INTERACTIONS; HUMANS; PHYLOGENY; PHYLOGEOGRAPHY; RNA, VIRAL;

EID: 84890022618     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2013.10.023     Document Type: Review

References (245)

1. CDC C.f.D.C.a.P. Foodborne transmission of hepatitis A-Massachusetts, 2001. MMWR Morb. Mortal. Wkly. Rep. 2003, 52:565-567.
2. Adzhubei A.A., Adzhubei I.A., Krasheninnikov I.A., Neidle S. Nonrandom usage of "degenerate" codons is related to protein three-dimensional structure. FEBS Lett. 1996, 399.
3. Alexopoulou L., Holt A.C., Medzhitov R., Flavell R.A. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001, 413:732-738.
4. Ali I.K., McKendrick L., Morley S.J., Jackson R.J. Activity of the hepatitis A virus IRES requires association between the cap-binding translation initiation factor (eIF4E) and eIF4G. J. Virol. 2001, 75:7854-7863.
5. Amado L.A., Villar L.M., de Paula V.S., Pinto M.A., Gaspar A.M. Exposure to multiple subgenotypes of hepatitis A virus during an outbreak using matched serum and saliva specimens. J. Med. Virol. 2011, 83:768-775.
6. Amon J.J., Devasia R., Xia G., Nainan O.V., Hall S., Lawson B., Wolthuis J.S., Macdonald P.D., Shepard C.W., Williams I.T., Armstrong G.L., Gabel J.A., Erwin P., Sheeler L., Kuhnert W., Patel P., Vaughan G., Weltman A., Craig A.S., Bell B.P., Fiore A. Molecular epidemiology of foodborne hepatitis a outbreaks in the United States, 2003. J. Infect. Dis. 2005, 192:1323-1330.
7. Apaire-Marchais V., Robertson B.H., Aubineau-Ferre V., Le Roux M.G., Leveque F., Schwartzbrod L., Billaudel S. Direct sequencing of hepatitis A virus strains isolated during an epidemic in France. Appl. Environ. Microbiol. 1995, 61:3977-3980.
8. Aragones L., Bosch A., Pinto R.M. Hepatitis A virus mutant spectra under the selective pressure of monoclonal antibodies: codon usage constraints limit capsid variability. J. Virol. 2008, 82:1688-1700.
9. Aragones L., Guix S., Ribes E., Bosch A., Pinto R.M. Fine-tuning translation kinetics selection as the driving force of codon usage bias in the hepatitis A virus capsid. PLoS Pathog. 2010, 6:e1000797.
10. Arankalle V.A., Sarada Devi K.L., Lole K.S., Shenoy K.T., Verma V., Haneephabi M. Molecular characterization of hepatitis A virus from a large outbreak from Kerala, India. Indian J. Med. Res. 2006, 123:760-769.
11. Asher L.V., Binn L.N., Mensing T.L., Marchwicki R.H., Vassell R.A., Young G.D. Pathogenesis of hepatitis A in orally inoculated owl monkeys (Aotus trivirgatus). J. Med. Virol. 1995, 47:260-268.
12. Bach J.F. Predictive medicine in autoimmune diseases: from the identification of genetic predisposition and environmental influence to precocious immunotherapy. Clin. Immunol. Immunopathol. 1994, 72:156-161.
13. Beard M.R., Cohen L., Lemon S.M., Martin A. Characterization of recombinant hepatitis A virus genomes containing exogenous sequences at the 2A/2B junction. J. Virol. 2001, 75:1414-1426.
14. Belalov I.S., Isaeva O.V., Lukashev A.N. Recombination in hepatitis A virus: evidence for reproductive isolation of genotypes. J. Gen. Virol. 2011, 92:860-872.
15. Belkaid Y., Tarbell K. Regulatory T cells in the control of host-microorganism interactions (*). Annu. Rev. Immunol. 2009, 27:551-589.
16. Benschop K.S., de Vries M., Minnaar R.P., Stanway G., van der Hoek L., Wolthers K.C., Simmonds P. Comprehensive full-length sequence analyses of human parechoviruses: diversity and recombination. J. Gen. Virol. 2010, 91:145-154.
17. Bialek S.R., George P.A., Xia G.L., Glatzer M.B., Motes M.L., Veazey J.E., Hammond R.M., Jones T., Shieh Y.C., Wamnes J., Vaughan G., Khudyakov Y., Fiore A.E. Use of molecular epidemiology to confirm a multistate outbreak of hepatitis A caused by consumption of oysters. Clin. Infect. Dis. 2007, 44:838-840.
18. Blair W.S., Li X., Semler B.L. A cellular cofactor facilitates efficient 3CD cleavage of the poliovirus P1 precursor. J. Virol. 1993, 67:2336-2343.
19. Bordi L., Rozera G., Scognamiglio P., Minosse C., Loffredo M., Antinori A., Narciso P., Ippolito G., Girardi E., Capobianchi M.R., Group G. Monophyletic outbreak of hepatitis A involving HIV-infected men who have sex with men, Rome, Italy 2008-2009. J. Clin. Virol. 2012, 54:26-29.
20. Borman A.M., Kean K.M. Intact eukaryotic initiation factor 4G is required for hepatitis A virus internal initiation of translation. Virology 1997, 237:129-136.
21. Borman A.M., Kirchweger R., Ziegler E., Rhoads R.E., Skern T., Kean K.M. EIF4G and its proteolytic cleavage products: effect on initiation of protein synthesis from capped, uncapped, and IRES-containing mRNAs. RNA 1997, 3:186-196.
22. Bosch A., Sanchez G., Le Guyader F., Vanaclocha H., Haugarreau L., Pinto R.M. Human enteric viruses in Coquina clams associated with a large hepatitis A outbreak. Water Sci. Technol. 2001, 43:61-65.
23. Braun E.A., Zajac A.J., Lemon S.M. In vitro characterization of an internal ribosome entry site (IRES) present within the 5' nontranslated region of hepatitis A virus RNA: comparison with the IRES of encephalomyocarditis virus. J. Virol. 1994, 68:1066-1074.
24. Brown B.A., Oberste M.S., Alexander J.P., Kennett M.L., Pallansh M.A. Molecular epidemiology and evolution of enterovirus 71 strains isolated from 1970 to 1998. J. Virol. 1999, 73:9969-9975.
25. Brown E.A., Jansen R.W., Lemon S.M. Characterization of a simian hepatitis A virus (HAV): antigenic and genetic comparison with human HAV. J. Virol. 1989, 63:4932-4937.
26. Bruisten S.M., van Steenbergen J.E., Pijl A.S., Niesters H.G., van Doornum G.J., Coutinho R.A. Molecular epidemiology of hepatitis A virus in Amsterdam, the Netherlands. J. Med. Virol. 2001, 63:88-95.
27. Cao J., Bi S., Meng Q., Shen L., Zheng H., Zhang Y. Genotyping of acute hepatitis a virus isolates from China, 2003-2008. J. Med. Virol. 2011, 83:1134-1141.
28. Cao J., Wang Y., Song H., Meng Q., Sheng L., Bian T., Mahemuti W., Yierhali A., Omata M., Bi S. Hepatitis A outbreaks in China during 2006: application of molecular epidemiology. Hepatol. Int. 2009, 3:356-363.
29. Carvalho C., Thomas H., Balogun K., Tedder R., Pebody R., Ramsay M., Ngui S. A possible outbreak of hepatitis A associated with semi-dried tomatoes, England, July-November 2011. Euro Surveill. 2012, 17.
30. Casanova J.L., Abel L. The human model: a genetic dissection of immunity to infection in natural conditions. Nat. Rev. Immunol. 2004, 4:55-66.
31. Casanova J.L., Abel L. Inborn errors of immunity to infection: the rule rather than the exception. J. Exp. Med. 2005, 202:197-201.
32. CDC Epidemiologic notes and reports hepatitis A among drug abusers. MMWR Surveill. Summ. 1988, 37:297-305.
33. Centers for Disease Control and Prevention (CDC) Surveillance for acute viral hepatitis -United States, 2007. MMWR Morb. Mortal. Wkly. Rep. 2009, 58:1-27.
34. Chancellor D.D., Tyagi S., Bazaco M.C., Bacvinskas S., Chancellor M.B., Dato V.M., de Miguel F. Green onions: potential mechanism for hepatitis A contamination. J. Food Prot. 2006, 69:1468-1472.
35. Chen B.J., Lamb R.A. Mechanisms for enveloped virus budding: can some viruses do without an ESCRT?. Virology 2008, 372:221-232.
36. Chitambar S., Joshi M., Lole K., Walimbe A., Vaidya S. Cocirculation of and coinfections with hepatitis A virus subgenotypes IIIA and IB in patients from Pune, western India. Hepatol. Res. 2007, 37:85-93.
37. Chobe L.P., Arankalle V.A. Investigation of a hepatitis A outbreak from Shimla Himachal Pradesh. Indian J. Med. Res. 2009, 130:179-184.
38. Chou T., Lakatos G. Clustered bottlenecks in mRNA translation and protein synthesis. Phys. Rev. Lett. 2004, 93:198101.
39. Cohen J.I., Ticehurst J.R., Purcell R.H., Buckler-White A., Baroudy B.M. Complete nucleotide sequence of wild-type hepatitis A virus: comparison with different strains of hepatitis A virus and other picornaviruses. J. Virol. 1987, 61:50-59.
40. Cordes S., Kusov Y., Heise T., Gauss-Muller V. La autoantigen suppresses IRES-dependent translation of the hepatitis A virus. Biochem. Biophys. Res. Commun. 2008, 368:1014-1019.
41. Costa-Mattioli M., Cristina J., Romero H., Perez-Bercof R., Casane D., Colina R., Garcia L., Vega I., Glikman G., Romanowsky V., Castello A., Nicand E., Gassin M., Billaudel S., Ferre V. Molecular evolution of hepatitis A virus: a new classification based on the complete VP1 protein. J. Virol. 2002, 76:9516-9525.
42. Costa-Mattioli M., Di Napoli A., Ferre V., Billaudel S., Perez-Bercoff R., Cristina J. Genetic variability of hepatitis A virus. J. Gen. Virol. 2003, 84:3191-3201.
43. Costa-Mattioli M., Domingo E., Cristina J. Analysis of sequential hepatitis A virus strains reveals coexistence of distinct viral subpopulations. J. Gen. Virol. 2006, 87:115-118.
44. Costa-Mattioli M., Ferre V., Casane D., Perez-Bercoff R., Coste-Burel M., Imbert-Marcille B.M., Andre E.C., Bressollette-Bodin C., Billaudel S., Cristina J. Evidence of recombination in natural populations of hepatitis A virus. Virology 2003, 311:51-59.
45. Cotter S.M., Sansom S., Long T., Koch E., Kellerman S., Smith F., Averhoff F., Bell B.P. Outbreak of hepatitis A among men who have sex with men: implications for hepatitis A vaccination strategies. J. Infect. Dis. 2003, 187:1235-1240.
46. Craig A.S., Watson B., Zink T.K., Davis J.P., Yu C., Schaffner W. Hepatitis A outbreak activity in the United States: responding to a vaccine-preventable disease. Am. J. Med. Sci. 2007, 334:180-183.
47. Cristina J., Costa-Mattioli M. Genetic variability and molecular evolution of hepatitis A virus. Virus Res. 2007, 127:151-157.
48. Crofts N., Cooper G., Stewart T., Kiely P., Coghlan P., Hearne P., Hocking J. Exposure to hepatitis A virus among blood donors, injecting drug users and prison entrants in Victoria. J. Viral Hepat. 1997, 4:333-338.
49. Cruz-Rivera M., Forbi J.C., Yamasaki L.H., Vazquez-Chacon C.A., Martinez-Guarneros A., Carpio-Pedroza J.C., Escobar-Gutierrez A., Ruiz-Tovar K., Fonseca-Coronado S., Vaughan G. Molecular epidemiology of viral diseases in the era of next generation sequencing. J Clin Virol 2013, 57(4):378-380.
50. Czaja A.J., Souto E.O., Bittencourt P.L., Cancado E.L., Porta G., Goldberg A.C., Donaldson P.T. Clinical distinctions and pathogenic implications of type 1 autoimmune hepatitis in Brazil and the United States. J. Hepatol. 2002, 37:302-308.
51. D'Andrea L., Pinto R.M., Bosch A., Musto H., Cristina J. A detailed comparative analysis on the overall codon usage patterns in Hepatitis A virus. Virus Res. 2011, 157:19-24.
52. Davidkin I., Zheleznova N., Jokinen S., Gorchakova O., Broman M., Mukomolov S. Molecular epidemiology of hepatitis A in St. Petersburg, Russia, 1997-2003. J. Med. Virol. 2007, 79:657-662.
53. de Paula V.S. Laboratory diagnosis of hepatitis A. Future Virol. 2012, 7:11.
54. De Paula V.S., Diniz-Mendes L., Villar L.M., Luz S.L., Silva L.A., Jesus M.S., da Silva N.M., Gaspar A.M. Hepatitis A virus in environmental water samples from the Amazon Basin. Water Res. 2007, 41:1169-1176.
55. de Paula V.S., Saback F.L., Gaspar A.M., Niel C. Mixed infection of a child care provider with hepatitis A virus isolates from subgenotypes IA and IB revealed by heteroduplex mobility assay. J. Virol. Methods 2003, 107:223-228.
56. De Serres G., Cromeans T.L., Levesque B., Brassard N., Barthe C., Dionne M., Prud'homme H., Paradis D., Shapiro C.N., Nainan O.V., Margolis H.S. Molecular confirmation of hepatitis A virus from well water: epidemiology and public health implications. J. Infect. Dis. 1999, 179:37-43.
57. Deka M., Bose M., Baruah B., Bose P.D., Medhi S., Bose S., Saikia A., Kar P. Role of CYP2E1 gene polymorphisms association with hepatitis risk in Northeast India. World J. Gastroenterol. 2010, 16:4800-4808.
58. Desbois D., Couturier E., Mackiewicz V., Graube A., Letort M.J., Dussaix E., Roque-Afonso A.M. Epidemiology and genetic characterization of hepatitis A virus genotype IIA. J. Clin. Microbiol. 2010, 48:3306-3315.
59. Domingo E., Sheldon J., Perales C. Viral quasispecies evolution. Microbiol. Mol. Biol. Rev. 2012, 76:159-216.
60. Dotzauer A., Gebhardt U., Bieback K., Gottke U., Kracke A., Mages J., Lemon S.M., Vallbracht A. Hepatitis A virus-specific immunoglobulin A mediates infection of hepatocytes with hepatitis A virus via the asialoglycoprotein receptor. J. Virol. 2000, 74:10950-10957.
61. Drake J.W., Holland J.J. Mutation rates among RNA viruses. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:13910-13913.
62. Ehrenfeld E., Teterina N.L. Initiation of translation of picornavirus RNAs: structure and function of the internal ribosome entry site. Molecular Biology of Picornaviruses 2002, 159-170. ASM Press, Washington, DC. B.L. Semler, E. Wimmer (Eds.).
63. Endo K., Takahashi M., Masuko K., Inoue K., Akahane Y., Okamoto H. Full-length sequences of subgenotype IIIA and IIIB hepatitis A virus isolates: characterization of genotype III HAV genomes. Virus Res. 2007, 126:116-127.
64. Escobar-Gutierrez A., Cruz-Rivera M., Ruiz-Tovar K., Vaughan G. Genetic relatedness among Japanese HAV isolates, 2010. J. Clin. Virol. 2012, 54:287-288.
65. Evans M.S., Clark T.F., Clark P.L. Conformations of co-translational folding intermediates. Protein Pept. Lett. 2005, 12:185-195.
66. Fainboim L., Canero Velasco M.C., Marcos C.Y., Ciocca M., Roy A., Theiler G., Capucchio M., Nuncifora S., Sala L., Zelazko M. Protracted, but not acute, hepatitis A virus infection is strongly associated with HLA-DRB*1301, a marker for pediatric autoimmune hepatitis. Hepatology 2001, 33:1512-1517.
67. Fainboim L., Marcos Y., Pando M., Capucchio M., Reyes G.B., Galoppo C., Badia I., Remondino G., Ciocca M., Ramonet M., et al. Chronic active autoimmune hepatitis in children. Strong association with a particular HLA-DR6 (DRB1*1301) haplotype. Hum. Immunol. 1994, 41:146-150.
68. Farci P. New insights into the HCV quasispecies and compartmentalization. Semin. Liver Dis. 2011, 31:356-374.
69. Farci P., Strazzera R., Alter H.J., Farci S., Degioannis D., Coiana A., Peddis G., Usai F., Serra G., Chessa L., Diaz G., Balestrieri A., Purcell R.H. Early changes in hepatitis C viral quasispecies during interferon therapy predict the therapeutic outcome. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:3081-3086.
70. Feigelstock D., Thompson P., Mattoo P., Zhang Y., Kaplan G.G. The human homolog of HAVcr-1 codes for a hepatitis A virus cellular receptor. J. Virol. 1998, 72:6621-6628.
71. Feng Z., Hensley L., McKnight K.L., Hu F., Madden V., Ping L., Jeong S.H., Walker C., Lanford R.E., Lemon S.M. A pathogenic picornavirus acquires an envelope by hijacking cellular membranes. Nature 2013, 496:367-371.
72. Fiore A.E. Hepatitis A transmitted by food. Clin. Infect. Dis. 2004, 38:705-715.
73. Flisiak R., Prokopowicz D., Jaroszewicz J., Flisiak I. Plasma transforming growth factor-beta(1) in acute viral hepatitis. Med. Sci. Monit. 2005, 11:CR304-CR308.
74. Forbi J.C., Agwale S.M., Ndip L.M., Esona M.D. Genetic analysis of hepatitis A virus variants circulating among children presenting with acute diarrhea in Cameroon. J. Med. Virol. 2012, 84:728-732.
75. Forbi J.C., Esona M.D., Agwale S.M. Molecular characterization of hepatitis A virus isolates from Nigeria. Intervirology 2013, 56:22-26.
76. Frank C., Walter J., Muehlen M., Jansen A., van Treeck U., Hauri A.M., Zoellner I., Rakha M., Hoehne M., Hamouda O., Schreier E., Stark K. Major outbreak of hepatitis A associated with orange juice among tourists, Egypt, 2004. Emerg. Infect. Dis. 2007, 13:156-158.
77. Fujiwara K., Kojima H., Yonemitsu Y., Yasui S., Imazeki F., Miki M., Suzuki K., Sakaida I., Okita K., Tanaka E., Omata M., Yokosuka O. Phylogenetic analysis of hepatitis A virus in sera from patients with hepatitis A of various severities. Liver Int. 2009, 29:838-845.
78. Fujiwara K., Yokosuka O., Ehata T., Saisho H., Saotome N., Suzuki K., Okita K., Kiyosawa K., Omata M. Association between severity of type A hepatitis and nucleotide variations in the 5' non-translated region of hepatitis A virus RNA: strains from fulminant hepatitis have fewer nucleotide substitutions. Gut 2002, 51:82-88.
79. Fujiwara K., Yokosuka O., Fukai K., Imazeki F., Saisho H., Omata M. Analysis of full-length hepatitis A virus genome in sera from patients with fulminant and self-limited acute type A hepatitis. J. Hepatol. 2001, 35:112-119.
80. Fujiwara K., Yokosuka O., Imazeki F., Saisho H., Miki M., Omata M. Do high levels of viral replication contribute to fulminant hepatitis A?. Liver Int. 2005, 25:194-195.
81. Fujiwara K., Yokosuka O., Imazeki F., Saisho H., Saotome N., Suzuki K., Okita K., Tanaka E., Omata M. Analysis of the genotype-determining region of hepatitis A viral RNA in relation to disease severities. Hepatol. Res. 2003, 25:124-134.
82. Gavrilin G.V., Cherkasova E.A., Lipskaya G.Y., Kew O.M., Agol V.I. Evolution of circulating wild poliovirus and of vaccine derived poliovirus in an immunodeficient patient: a unifying model. J. Virol. 2000, 74:7381-7390.
83. Ge D., Fellay J., Thompson A.J., Simon J.S., Shianna K.V., Urban T.J., Heinzen E.L., Qiu P., Bertelsen A.H., Muir A.J., Sulkowski M., McHutchison J.G., Goldstein D.B. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 2009, 461:399-401.
84. Gharbi-Khelifi H., Ferre V., Sdiri K., Berthome M., Fki L., Harrath R., Billaudel S., Aouni M. Hepatitis A in Tunisia: phylogenetic analysis of hepatitis A virus from 2001 to 2004. J. Virol. Methods 2006, 138:109-116.
85. Gitlin L., Barchet W., Gilfillan S., Cella M., Beutler B., Flavell R.A., Diamond M.S., Colonna M. Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:8459-8464.
86. Graff J., Cha J., Blyn L.B., Ehrenfeld E. Interaction of poly(rC) binding protein 2 with the 5' noncoding region of hepatitis A virus RNA and its effects on translation. J. Virol. 1998, 72:9668-9675.
87. Grinde B., Stene-Johansen K., Sharma B., Hoel T., Jensenius M., Skaug K. Characterisation of an epidemic of hepatitis A virus involving intravenous drug abusers-infection by needle sharing?. J. Med. Virol. 1997, 53:69-75.
88. Guillot S., Caro V., Cuervo N., Korotkova E., Combiescu M., Persu A., Aubert-Combiescu A., Delpeyroux F., Crainic R. Natural genetic exchanges between vaccine and wild poliovirus strains in humans. J. Virol. 2000, 74:8434-8443.
89. Halliday M.L., Kang L.Y., Zhou T.K., Hu M.D., Pan Q.C., Fu T.Y., Huang Y.S., Hu S.L. An epidemic of hepatitis-a attributable to the ingestion of raw clams in Shanghai, China. J. Infect. Dis. 1991, 164:852-859.
90. Hernandez-Morga J., Leon-Felix J., Peraza-Garay F., Gil-Salas B.G., Chaidez C. Detection and characterization of hepatitis A virus and Norovirus in estuarine water samples using ultrafiltration-RT-PCR integrated methods. J. Appl. Microbiol. 2009, 106:1579-1590.
91. Hill A.V. The genomics and genetics of human infectious disease susceptibility. Annu. Rev. Genomics Hum. Genet. 2001, 2:373-400.
92. Hoekema A., Kastelein R.A., Vasser M., de Boer H.A. Codon replacement in the PGK1 gene of Saccharomyces cerevisiae: experimental approach to study the role of biased codon usage in gene expression. Mol. Cell. Biol. 1987, 7:2914-2924.
93. Hohler T., Reuss E., Evers N., Dietrich E., Rittner C., Freitag C.M., Vollmar J., Schneider P.M., Fimmers R. Differential genetic determination of immune responsiveness to hepatitis B surface antigen and to hepatitis A virus: a vaccination study in twins. Lancet 2002, 360:991-995.
94. Hollinger F.B., Emerson S.U. Hepatitis A virus. Fields Virology 2001, 799-840. Lippincott Williams & Wilkins, New York. fourth ed. D.M. Knipe, P.M. Howley (Eds.).
95. Holmes E.C. The RNA virus quasispecies: fact or fiction?. J. Mol. Biol. 2010, 400:271-273.
96. Hornung V., Ellegast J., Kim S., Brzozka K., Jung A., Kato H., Poeck H., Akira S., Conzelmann K.K., Schlee M., Endres S., Hartmann G. 5'-Triphosphate RNA is the ligand for RIG-I. Science 2006, 314:994-997.
97. Hurley J.H. The ESCRT complexes. Crit. Rev. Biochem. Mol. Biol. 2010, 45:463-487.
98. Jacobsen K.H., Wiersma S.T. Hepatitis A virus seroprevalence by age and world region, 1990 and 2005. Vaccine 2010, 28:6653-6657.
99. Jia X.Y., Summers D.F., Ehrenfeld E. Primary cleavage of the HAV capsid protein precursor in the middle of the proposed 2A coding region. Virology 1993, 193:515-519.
100. Jindal M., Rana S.S., Gupta R.K., Das K., Kar P. Serological study of hepatitis A virus infection amongst the students of a medical college in Delhi & evaluation of the need of vaccination. Indian J. Med. Res. 2002, 115:1-4.
101. Joshi M.S., Walimbe A.M., Chitambar S.D. Evaluation of genomic regions of hepatitis A virus for phylogenetic analysis: suitability of the 2C region for genotyping. J. Virol. Methods 2008, 153:36-42.
102. Kanda T., Gauss-Muller V., Cordes S., Tamura R., Okitsu K., Shuang W., Nakamoto S., Fujiwara K., Imazeki F., Yokosuka O. Hepatitis A virus (HAV) proteinase 3C inhibits HAV IRES-dependent translation and cleaves the polypyrimidine tract-binding protein. J. Viral Hepat. 2010, 17:618-623.
103. Kanda T., Yokosuka O., Imazeki F., Fujiwara K., Nagao K., Saisho H. Amantadine inhibits hepatitis A virus internal ribosomal entry site-mediated translation in human hepatoma cells. Biochem. Biophys. Res. Commun. 2005, 331:621-629.
104. Kang D.C., Gopalkrishnan R.V., Wu Q., Jankowsky E., Pyle A.M., Fisher P.B. Mda-5: An interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:637-642.
105. Kaplan G., Totsuka A., Thompson P., Akatsuka T., Moritsugu Y., Feinstone S.M. Identification of a surface glycoprotein on African green monkey kidney cells as a receptor for hepatitis A virus. EMBO J. 1996, 15:4282-4296.
106. Karayiannis P., Alexopoulou A., Hadziyannis S., Thursz M., Watts R., Seito S., Thomas H.C. Fulminant hepatitis associated with hepatitis B virus e antigen-negative infection: importance of host factors. Hepatology 1995, 22:1628-1634.
107. Kato H., Takeuchi O., Mikamo-Satoh E., Hirai R., Kawai T., Matsushita K., Hiiragi A., Dermody T.S., Fujita T., Akira S. Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J. Exp. Med. 2008, 205:1601-1610.
108. Kawai T., Akira S. Toll-like receptor and RIG-I-like receptor signaling. Ann. N.Y. Acad. Sci. 2008, 1143:1-20.
109. Kim H.S., Jeong S.H., Jang J.H., Myung H.J., Kim J.W., Bang S.M., Song S.H., Kim H., Yun H.S. Coinfection of hepatitis A virus genotype IA and IIIA complicated with autoimmune hemolytic anemia, prolonged cholestasis, and false-positive immunoglobulin M anti-hepatitis E virus: a case report. Korean J. Hepatol. 2011, 17:323-327.
110. Kim H.Y., Eyheramonho M.B., Pichavant M., Cambaceres C.G., Matangkasombut P., Cervio G., Kuperman S., Moreiro R., Konduru K., Manangeeswaran M., Freeman G.J., Kaplan G.G., DeKruyff R.H., Umetsu D.T., Rosenzweig S.D. A polymorphism in TIM1 is associated with susceptibility to severe hepatitis A virus infection in humans. J. Clin. Invest. 2011, 121:1111-1118.
111. Kim H.Y., Eyheramonho M.B., Pichavant M., Gonzalez Cambaceres C., Matangkasombut P., Cervio G., Kuperman S., Moreiro R., Konduru K., Manangeeswaran M., Freeman G.J., Kaplan G.G., DeKruyff R.H., Umetsu D.T., Rosenzweig S.D. A polymorphism in TIM1 is associated with susceptibility to severe hepatitis A virus infection in humans. J. Clin. Invest. 2011, 121:1111-1118.
112. Klevens R.M., Miller J.T., Iqbal K., Thomas A., Rizzo E.M., Hanson H., Sweet K., Phan Q., Cronquist A., Khudyakov Y., Xia G.L., Spradling P. The evolving epidemiology of hepatitis a in the United States: incidence and molecular epidemiology from population-based surveillance, 2005-2007. Arch. Intern. Med. 2010, 170:1811-1818.
113. Kuechler E., Seipelt J., Liebig H.-D., Sommergruber W. Picornavirus proteinase-mediated shutoff of host cell translation: direct cleavage of a cellular initiation factor. Molecular Biology of Picornaviruses 2002, 301-312. ASM Press, Washington, DC. B.L. Semler, E. Wimmer (Eds.).
114. Kulkarni M.A., Walimbe A.M., Cherian S., Arankalle V.A. Full length genomes of genotype IIIA hepatitis A virus strains (1995-2008) from India and estimates of the evolutionary rates and ages. Infect. Genet. Evol. 2009, 9:1287-1294.
115. Kunkel T.A. Exonucleolytic proofreading. Cell 1988, 53:837-840.
116. Lanford R.E., Feng Z., Chavez D., Guerra B., Brasky K.M., Zhou Y., Yamane D., Perelson A.S., Walker C.M., Lemon S.M. Acute hepatitis A virus infection is associated with a limited type I interferon response and persistence of intrahepatic viral RNA. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:11223-11228.
117. Lei Y., Moore C.B., Liesman R.M., O'Connor B.P., Bergstralh D.T., Chen Z.J., Pickles R.J., Ting J.P. MAVS-mediated apoptosis and its inhibition by viral proteins. PLoS One 2009, 4:e5466.
118. Lemon S.M. Induction and evasion of innate antiviral responses by hepatitis C virus. J. Biol. Chem. 2010, 285:22741-22747.
119. Lemon S.M., Murphy P.C., Shields P.A., Ping L.H., Feinstone S.M., Cromeans T., Jansen R.W. Antigenic and genetic variation in cytopathic hepatitis A virus variants arising during persistent infection: evidence for genetic recombination. J. Virol. 1991, 65:2056-2065.
120. Leong L.E.C., Cornell C.T., Semler B.L. Processing determinants and functions of cleavage products of picornavirus. Molecular Biology of Picornaviruses 2002, 187-198. ASM Press, Washington, DC. B.L. Semler, E. Wimmer (Eds.).
121. Liu W., Zhai J., Liu J., Xie Y. Identification of recombination between subgenotypes IA and IB of hepatitis A virus. Virus Genes 2010, 40:222-224.
122. Lukashev A.N. Recombination among picornaviruses. Rev. Med. Virol. 2010, 20:327-337.
123. Manangeeswaran M., Jacques J., Tami C., Konduru K., Amharref N., Perrella O., Casasnovas J.M., Umetsu D.T., Dekruyff R.H., Freeman G.J., Perrella A., Kaplan G.G. Binding of hepatitis A virus to its cellular receptor 1 inhibits T-regulatory cell functions in humans. Gastroenterology 2012, 142(1516-1525):e1513.
124. Manry J., Quintana-Murci L. A genome-wide perspective of human diversity and its implications in infectious disease. Cold Spring Harb. Perspect. Med. 2013, 3:a012450.
125. Manso C.F., Polo D., Vilarino M.L., Romalde J.L. Genotyping of hepatitis A virus detected in bivalve shellfish in Galicia (NW Spain). Water Sci. Technol. 2010, 61:15-24.
126. Martin A., Lemon S.M. The molecular biology of hepatitis A virus. Hepatitis Viruses 2002, 23-50. Kluwer Academic Publishers, Norwell, MA. J.-H. Ou (Ed.).
127. McCartney S.A., Thackray L.B., Gitlin L., Gilfillan S., Virgin H.W., Colonna M. MDA-5 recognition of a murine norovirus. PLoS Pathog. 2008, 4:e1000108.
128. McFarland N., Dryden M., Ramsay M., Tedder R.S., Ngui S.L., Winchester H.A.V.O.T. An outbreak of hepatitis A affecting a nursery school and a primary school. Epidemiol. Infect. 2011, 139:336-343.
129. McIntire J.J., Umetsu S.E., Akbari O., Potter M., Kuchroo V.K., Barsh G.S., Freeman G.J., Umetsu D.T., DeKruyff R.H. Identification of Tapr (an airway hyperreactivity regulatory locus) and the linked Tim gene family. Nat. Immunol. 2001, 2:1109-1116.
130. McIntire J.J., Umetsu S.E., Macaubas C., Hoyte E.G., Cinnioglu C., Cavalli-Sforza L.L., Barsh G.S., Hallmayer J.F., Underhill P.A., Risch N.J., Freeman G.J., DeKruyff R.H., Umetsu D.T. Immunology: hepatitis A virus link to atopic disease. Nature 2003, 425:576.
131. Medzhitov R., Janeway C.A. Decoding the patterns of self and nonself by the innate immune system. Science 2002, 296:298-300.
132. Meylan E., Curran J., Hofmann K., Moradpour D., Binder M., Bartenschlager R., Tschopp J. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 2005, 437:1167-1172.
133. Mitsui T., Tsukamoto Y., Hirose A., Suzuki S., Yamazaki C., Masuko K., Tsuda F., Endo K., Takahashi M., Okamoto H. Distinct changing profiles of hepatitis A and E virus infection among patients with acute hepatitis, patients on maintenance hemodialysis and healthy individuals in Japan. J. Med. Virol. 2006, 78:1015-1024.
134. Morais L.M., de Paula V.S., Arantes M.R., Oliveira M.L., Gaspar A.M. Early infection and asymptomatic spread of hepatitis A virus in a public child care center in Rio de Janeiro, Brazil: should attending children under two years of age be vaccinated?. Mem. Inst. Oswaldo Cruz 2006, 101:401-405.
135. Moratorio G., Costa-Mattioli M., Piovani R., Romero H., Musto H., Cristina J. Bayesian coalescent inference of hepatitis A virus populations: evolutionary rates and patterns. J. Gen. Virol. 2007, 88:3039-3042.
136. Mueller S., Papamichail D., Coleman J.R., Skiena S., Wimmer E. Reduction of the rate of poliovirus protein synthesis through large-scale codon deoptimization causes attenuation of viral virulence by lowering specific infectivity. J. Virol. 2006, 80:9687-9696.
137. Mukomolov S., Kontio M., Zheleznova N., Jokinen S., Sinayskaya E., Stalevskaya A., Davidkin I. Increased circulation of hepatitis A virus genotype IIIA over the last decade in St Petersburg, Russia. J. Med. Virol. 2012, 84:1528-1534.
138. Munne M.S., Vladimirsky S., Moreiro R., Ciocca M., Cuarterolo M., Otegui L., Soto S., Brajterman L., Castro R., Sasbon J., Gianivelli S., Buamscha D., Quarleri J., Gonzalez J.E. Molecular characterization of hepatitis A virus in children with fulminant hepatic failure in Argentina. Liver Int. 2008, 28:47-53.
139. Nainan O.V., Armstrong G.L., Han X.H., Williams I., Bell B.P., Margolis H.S. Hepatitis a molecular epidemiology in the United States, 1996-1997: sources of infection and implications of vaccination policy. J. Infect. Dis. 2005, 191:957-963.
140. Nainan O.V., Brinton M.A., Margolis H.S. Identification of amino acids located in the antibody binding sites of human hepatitis A virus. Virology 1992, 191:984-987.
141. Nainan O.V., Margolis H.S., Robertson B.H., Balayan M., Brinton M.A. Sequence analysis of a new hepatitis A virus naturally infecting cynomolgus macaques (Macaca fascicularis). J. Gen. Virol. 1991, 72(Pt 7):1685-1689.
142. Nainan O.V., Xia G., Vaughan G., Margolis H.S. Diagnosis of hepatitis a virus infection: a molecular approach. Clin. Microbiol. Rev. 2006, 19:63-79.
143. Nakajima T., Wooding S., Satta Y., Jinnai N., Goto S., Hayasaka I., Saitou N., Guan-Jun J., Tokunaga K., Jorde L.B., Emi M., Inoue I. Evidence for natural selection in the HAVCR1 gene: high degree of amino-acid variability in the mucin domain of human HAVCR1 protein. Genes Immun. 2005, 6:398-406.
144. Nejati A., Makvandi M., Samarbafzadeh A., Neisi N., Moradzadegan H. Molecular epidemiology of hepatitis A virus in patients in the Ahwaz region of Iran. J. Med. Virol. 2012, 84:582-586.
145. Ngui S.L., Granerod J., Jewes L.A., Crowcroft N.S., Teo C.G., Network H.A.O.I. Outbreaks of hepatitis A in England and Wales associated with two co-circulating hepatitis A virus strains. J. Med. Virol. 2008, 80:1181-1188.
146. Niu M.T., Polish L.B., Robertson B.H., Khanna B.K., Woodruff B.A., Shapiro C.N., Miller M.A., Smith J.D., Gedrose J.K., Alter M.J., et al. Multistate outbreak of hepatitis A associated with frozen strawberries. J. Infect. Dis. 1992, 166:518-524.
147. Normann A., Badur S., Onel D., Kilic A., Sidal M., Larouze B., Massari V., Muller J., Flehmig B. Acute hepatitis A virus infection in Turkey. J. Med. Virol. 2008, 80:785-790.
148. O'Donovan D., Cooke R.P., Joce R., Eastbury A., Waite J., Stene-Johansen K. An outbreak of hepatitis A amongst injecting drug users. Epidemiol. Infect. 2001, 127:469-473.
149. O'Grady J.G. Fulminant hepatitis in patients with chronic liver disease. J. Viral Hepat. 2000, 7(Suppl. 1):9-10.
150. Pando M., Larriba J., Fernandez G.C., Fainboim H., Ciocca M., Ramonet M., Badia I., Daruich J., Findor J., Tanno H., Canero-Velasco C., Fainboim L. Pediatric and adult forms of type I autoimmune hepatitis in Argentina: evidence for differential genetic predisposition. Hepatology 1999, 30:1374-1380.
151. Parker J. Errors and alternatives in reading the universal genetic code. Microbiol. Rev. 1989, 53:273-298.
152. Pelletier A.R., Mehta P.J., Burgess D.R., Bondeson L.M., Carson P.J., Rea V.E., Sharapov U.M., Hu D.J. An outbreak of hepatitis A among primary and secondary contacts of an international adoptee. Public Health Rep. 2010, 125:642-646.
153. Perevoscikovs J., Lucenko I., Magone S., Brila A., Curikova J., Vennema H. Community-wide outbreak of hepatitis A in Latvia in 2008 - an update. Euro Surveill. 2009, 14.
154. Perez-Sautu U., Costafreda M.I., Lite J., Sala R., Barrabeig I., Bosch A., Pinto R.M. Molecular epidemiology of hepatitis A virus infections in Catalonia, Spain, 2005-2009: circulation of newly emerging strains. J. Clin. Virol. 2011, 52:98-102.
155. Perrella A., Vitiello L., Atripaldi L., Sbreglia C., Grattacaso S., Bellopede P., Patarino T., Morelli G., Altamura S., Racioppi L., Perrella O. Impaired function of CD4+/CD25+ T regulatory lymphocytes characterizes the self-limited hepatitis A virus infection. J. Gastroenterol. Hepatol. 2008, 23:e105-e110.
156. Perrett K., Granerød J., Crowcroft N., Carlisle R. Changing epidemiology of hepatitis A: should we be doing more to vaccinate injecting drug users?. Commun. Dis. Public Health 2003, 6:97-100.
157. Picard C., Casanova J.L., Abel L. Mendelian traits that confer predisposition or resistance to specific infections in humans. Curr. Opin. Immunol. 2006, 18:383-390.
158. Pinto R.M., Alegre D., Dominguez A., El-Senousy W.M., Sanchez G., Villena C., Costafreda M.I., Aragones L., Bosch A. Hepatitis A virus in urban sewage from two Mediterranean countries. Epidemiol. Infect. 2007, 135:270-273.
159. Pinto R.M., Aragones L., Costafreda M.I., Ribes E., Bosch A. Codon usage and replicative strategies of hepatitis A virus. Virus Res. 2007, 127:158-163.
160. Pinto R.M., Aragones L., Costafreda M.I., Ribes E., Bosch A. Codon usage and replicative strategies of hepatitis A virus. Virus Res. 2007, 127:158-163.
161. Plotch S.J., Palant O. Poliovirus protein 3AB forms a complex with and stimulates the activity of the viral RNA polymerase, 3Dpol. J. Virol. 1995, 69:7169-7179.
162. Pond S.L., Murrell B., Poon A.F. Evolution of viral genomes: interplay between selection, recombination, and other forces. Methods Mol. Biol. 2012, 856:239-272.
163. Poovorawan Y., Theamboonlers A., Chongsrisawat V., Jantaradsamee P., Chutsirimongkol S., Tangkijvanich P. Clinical features and molecular characterization of hepatitis A virus outbreak in a child care center in Thailand. J. Clin. Virol. 2005, 32:24-28.
164. Prado T., Fumian T.M., Miagostovich M.P., Gaspar A.M. Monitoring the hepatitis A virus in urban wastewater from Rio de Janeiro, Brazil. Trans. R. Soc. Trop. Med. Hyg. 2012, 106:104-109.
165. Prato R., Lopalco P.L., Chironna M., Germinario C., Quarto M. An outbreak of hepatitis A in Southern Italy: the case for vaccinating food handlers. Epidemiol. Infect. 2006, 134:799-802.
166. Probst C., Jecht M., Gauss-Muller V. Processing of proteinase precursors and their effect on hepatitis A virus particle formation. J. Virol. 1998, 72:8013-8020.
167. Probst C., Jecht M., Gauss-Muller V. Intrinsic signals for the assembly of hepatitis A virus particles. Role of structural proteins VP4 and 2A. J. Biol. Chem. 1999, 274:4527-4531.
168. Purdy M.A., Gonzales A.C., Dimitrova Z., Khudyakov Y. Supragenotypic groups of the hepatitis B virus genome. J. Gen. Virol. 2008, 89:1179-1183.
169. Qu L., Feng Z., Yamane D., Liang Y., Lanford R.E., Li K., Lemon S.M. Disruption of TLR3 signaling due to cleavage of TRIF by the hepatitis A virus protease-polymerase processing intermediate, 3CD. PLoS Pathog. 2011, 7:e1002169.
170. Qu L., Lemon S.M. Hepatitis A and hepatitis C viruses: divergent infection outcomes marked by similarities in induction and evasion of interferon responses. Semin. Liver Dis. 2010, 30:319-332.
171. Quintana-Murci L., Alcais A., Abel L., Casanova J.L. Immunology in natura: clinical, epidemiological and evolutionary genetics of infectious diseases. Nat. Immunol. 2007, 8:1165-1171.
172. Rahaman S.M., Chira P., Koff R.S. Idiopathic autoimmune chronic hepatitis triggered by hepatitis A. Am. J. Gastroenterol. 1994, 89:106-108.
173. Rebsamen M., Meylan E., Curran J., Tschopp J. The antiviral adaptor proteins Cardif and Trif are processed and inactivated by caspases. Cell Death Differ. 2008, 15:1804-1811.
174. Redondo N., Sanz M.A., Steinberger J., Skern T., Kusov Y., Carrasco L. Translation directed by hepatitis A virus IRES in the absence of active eIF4F complex and eIF2. PLoS One 2012, 7:e52065.
175. Rico-Hesse R., Pallansch M.A., Nottay B.K., Kew O.M. Geographic distribution of wild poliovirus type 1 genotypes. Virology 1987, 160:311-322.
176. Robertson B.H., Averhoff F., Cromeans T.L., Han X., Khoprasert B., Nainan O.V., Rosenberg J., Paikoff L., DeBess E., Shapiro C.N., Margolis H.S. Genetic relatedness of hepatitis A virus isolates during a community-wide outbreak. J. Med. Virol. 2000, 62:144-150.
177. Robertson B.H., Jansen R.W., Khanna B., Totsuka A., Nainan O.V., Siegl G., Widell A., Margolis H.S., Isomura S., Ito K., Ishizu T., Moritzugu Y., Lemon S.M. Genetic relatedness of hepatitis A virus strains recovered from different geographical regions. J. Gen. Virol. 1992, 73(Pt. 6):1365-1377.
178. Robertson B.H., Khanna B., Nainan O.V., Margolis H.S. Epidemiologic patterns of wild-type hepatitis A virus determined by genetic variation. J. Infect. Dis. 1991, 163:286-292.
179. Robesyn E., De Schrijver K., Wollants E., Top G., Verbeeck J., Van Ranst M. An outbreak of hepatitis A associated with the consumption of raw beef. J. Clin. Virol. 2009, 44:207-210.
180. Robinson M., Lilley R., Little S., Emtage J.S., Yarranton G., Stephens P., Millican A., Eaton M., Humphreys G. Codon usage can affect efficiency of translation of genes in Escherichia coli. Nucleic Acids Res. 1984, 12:6663-6671.
181. Rodrigues L., Pista A., Oliveira A., Agua-Doce I., Manita C., Paixao M.T. Molecular epidemiology of hepatitis A virus in a group of Portuguese citizens living in Lisbon area. J. Med. Virol. 2007, 79:483-487.
182. Rodriguez-Manzanet R., DeKruyff R., Kuchroo V.K., Umetsu D.T. The costimulatory role of TIM molecules. Immunol. Rev. 2009, 229:259-270.
183. Ros J.E., Libbrecht L., Geuken M., Jansen P.L., Roskams T.A. High expression of MDR1, MRP1, and MRP3 in the hepatic progenitor cell compartment and hepatocytes in severe human liver disease. J. Pathol. 2003, 200:553-560.
184. Rossmann M.G., Arnold E., Erickson J.W., Frankenberger E.A., Griffith J.P., Hecht H.J., Johnson J.E., Kamer G., Luo M., Mosser A.G., et al. Structure of a human common cold virus and functional relationship to other picornaviruses. Nature 1985, 317:145-153.
185. Roy K., Howie H., Sweeney C., Parry J., Molyneaux P., Goldberg D., Taylor A. Hepatitis A virus and injecting drug misuse in Aberdeen, Scotland: a case-control study. J. Viral Hepat. 2004, 11:277-282.
186. Saito S., Ota S., Yamada E., Inoko H., Ota M. Allele frequencies and haplotypic associations defined by allelic DNA typing at HLA class I and class II loci in the Japanese population. Tissue Antigens 2000, 56:522-529.
187. Saito T., Owen D.M., Jiang F., Marcotrigiano J., Gale M. Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA. Nature 2008, 454:523-527.
188. Sanchez G., Bosch A., Gomez-Mariano G., Domingo E., Pinto R.M. Evidence for quasispecies distributions in the human hepatitis A virus genome. Virology 2003, 315:34-42.
189. Sanchez G., Bosch A., Pinto R.M. Genome variability and capsid structural constraints of hepatitis A virus. J. Virol. 2003, 77:452-459.
190. Sanchez G., Pinto R.M., Vanaclocha H., Bosch A. Molecular characterization of hepatitis a virus isolates from a transcontinental shellfish-borne outbreak. J. Clin. Microbiol. 2002, 40:4148-4155.
191. Sánchez G., Pintó R.M., Vanaclocha H., Bosch A. Molecular characterization of hepatitis a virus isolates from a transcontinental shellfish-borne outbreak. J. Clin. Microbiol. 2002, 40:4148-4155.
192. Santos D.R., Villar L.M., Paula V.S., Lima G.S., Gaspar A.M. Hepatitis A virus subgenotypes dissemination during a community outbreak in a surrounding region of Rio de Janeiro. Mem. Inst. Oswaldo Cruz 2008, 103:254-258.
193. Santti J., Hyypia T., Kinnunen L., Salminen M. Evidence of recombination among enteroviruses. J. Virol. 1999, 73:8741-8749.
194. Sasbon J.S., Buamscha D., Gianivelli S., Imventarza O., Devictor D., Moreiro R., Cambaceres C., Salip G., Ciocca M., Cuarterolo M., Vladimirsky S., Otegui L., Castro R., Brajterman L., Soto S., Gonzalez J., Munne M.S. Clinical implications of hepatitis A virus ribonucleic acid detection and genotyping in acute liver failure in children in Argentina. Pediatr. Crit. Care Med. 2010, 11:385-389.
195. Schmid D., Fretz R., Buchner G., König C., Perner H., Sollak R., Tratter A., Hell M., Maass M., Strasser M., Allerberger F. Foodborne outbreak of hepatitis A, November 2007-January 2008, Austria. Eur. J. Clin. Microbiol. Infect. Dis. 2009, 28:385-391.
196. Schultheiss T., Kusov Y.Y., Gauss-Muller V. Proteinase 3C of hepatitis A virus (HAV) cleaves the HAV polyprotein P2-P3 at all sites including VP1/2A and 2A/2B. Virology 1994, 198:275-281.
197. Segev A., Hadari R., Zehavi T., Schneider M., Hershkoviz R., Mekori Y.A. Lupus-like syndrome with submassive hepatic necrosis associated with hepatitis A. J. Gastroenterol. Hepatol. 2001, 16:112-114.
198. Seth R.B., Sun L., Ea C.K., Chen Z.J. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 2005, 122:669-682.
199. Shieh Y.C., Khudyakov Y.E., Xia G., Ganova-Raeva L.M., Khambaty F.M., Woods J.W., Veazey J.E., Motes M.L., Glatzer M.B., Bialek S.R., Fiore A.E. Molecular confirmation of oysters as the vector for hepatitis A in a 2005 multistate outbreak. J. Food Prot. 2007, 70:145-150.
200. Silberstein E., Xing L., van de Beek W., Lu J., Cheng H., Kaplan G.G. Alteration of hepatitis A virus (HAV) particles by a soluble form of HAV cellular receptor 1 containing the immunoglobin-and mucin-like regions. J. Virol. 2003, 77:8765-8774.
201. Sorensen M.A., Kurland C.G., Pedersen S. Codon usage determines translation rate in Escherichia coli. J. Mol. Biol. 1989, 207:365-377.
202. Spada E., Genovese D., Tosti M.E., Mariano A., Cuccuini M., Proietti L., Giuli C.D., Lavagna A., Crapa G.E., Morace G., Taffon S., Mele A., Rezza G., Rapicetta M. An outbreak of hepatitis A virus infection with a high case-fatality rate among injecting drug users. J. Hepatol. 2005, 43:958-964.
203. Stapleton J.T., Lemon S.M. Neutralization escape mutants define a dominant immunogenic neutralization site on hepatitis A virus. J. Virol. 1987, 61:491-498.
204. Stene-Johansen K., Jonassen T., Skaug K. Characterization and genetic variability of hepatitis A virus genotype IIIA. J. Gen. Virol. 2005, 86:2739-2745.
205. Stene-Johansen K., Tjon G., Schreier E., Bremer V., Bruisten S., Ngui S.L., King M., Pinto R.M., Aragones L., Mazick A., Corbet S., Sundqvist L., Blystad H., Norder H., Skaug K. Molecular epidemiological studies show that hepatitis A virus is endemic among active homosexual men in Europe. J. Med. Virol. 2007, 79:356-365.
206. Sui L., Zhang W., Chen Y., Zheng Y., Wan T., Yang Y., Fang G., Mao J., Cao X. Human membrane protein Tim-3 facilitates hepatitis A virus entry into target cells. Int. J. Mol. Med. 2006, 17:1093-1099.
207. Sulbaran Y., Gutierrez C.R., Marquez B., Rojas D., Sanchez D., Navas J., Rovallo E., Pujol F.H. Hepatitis A virus genetic diversity in Venezuela: exclusive circulation of subgenotype IA and evidence of quasispecies distribution in the isolates. J. Med. Virol. 2010, 82:1829-1834.
208. Syed N.A., Hearing S.D., Shaw I.S., Probert C.S., Brooklyn T.N., Caul E.O., Barry R.E., Sarangi J. Outbreak of hepatitis A in the injecting drug user and homeless populations in Bristol: control by a targeted vaccination programme and possible parenteral transmission. Eur. J. Gastroenterol. Hepatol. 2003, 15:901-906.
209. Takahashi H., Yotsuyanagi H., Yasuda K., Koibuchi T., Suzuki M., Kato T., Nakamura T., Iwamoto A., Nishioka K., Iino S., Koike K., Itoh F. Molecular epidemiology of hepatitis A virus in metropolitan areas in Japan. J. Gastroenterol. 2006, 41:981-986.
210. Takeuchi O., Akira S. Innate immunity to virus infection. Immunol. Rev. 2009, 227:75-86.
211. Tallo T., Norder H., Tefanova V., Ott K., Ustina V., Prukk T., Solomonova O., Schmidt J., Zilmer K., Priimagi L., Krispin T., Magnius L.O. Sequential changes in hepatitis A virus genotype distribution in Estonia during 1994 to 2001. J. Med. Virol. 2003, 70:187-193.
212. Tallon L.A., Love D.C., Moore Z.S., Sobsey M.D. Recovery and sequence analysis of hepatitis a virus from springwater implicated in an outbreak of acute viral hepatitis. Appl. Environ. Microbiol. 2008, 74:6158-6160.
213. Tapia-Conyer R., Santos J.I., Cavalcanti A.M., Urdaneta E., Rivera L., Manterola A., Potin M., Ruttiman R., Tanaka Kido J. Hepatitis A in Latin America: a changing epidemiologic pattern. Am. J. Trop. Med. Hyg. 1999, 61:825-829.
214. Taylor M.B. Molecular epidemiology of South African strains of hepatitis A virus: 1982-1996. J. Med. Virol. 1997, 51:273-279.
215. Tjon G., Xiridou M., Coutinho R., Bruisten S. Different transmission patterns of hepatitis A virus for two main risk groups as evidenced by molecular cluster analysis. J. Med. Virol. 2007, 79:488-494.
216. Tjon G.M., Gotz H., Koek A.G., de Zwart O., Mertens P.L., Coutinho R.A., Bruisten S.M. An outbreak of hepatitis A among homeless drug users in Rotterdam, The Netherlands. J. Med. Virol. 2005, 77:360-366.
217. Tsarev S.A., Emerson S.U., Balayan M.S., Ticehurst J., Purcell R.H. Simian hepatitis A virus (HAV) strain AGM-27: comparison of genome structure and growth in cell culture with other HAV strains. J. Gen. Virol. 1991, 72(Pt. 7):1677-1683.
218. Tsatsralt-Od B., Takahashi M., Endo K., Agiimaa D., Buyankhuu O., Okamoto H. Comparison of hepatitis A and E virus infections among healthy children in Mongolia: evidence for infection with a subgenotype IA HAV in children. J. Med. Virol. 2007, 79:18-25.
219. Umetsu S.E., Lee W.L., McIntire J.J., Downey L., Sanjanwala B., Akbari O., Berry G.J., Nagumo H., Freeman G.J., Umetsu D.T., DeKruyff R.H. TIM-1 induces T cell activation and inhibits the development of peripheral tolerance. Nat. Immunol. 2005, 6:447-454.
220. van Steenbergen J.E., Tjon G., van den Hoek A., Koek A., Coutinho R.A., Bruisten S.M. Two years' prospective collection of molecular and epidemiological data shows limited spread of hepatitis A virus outside risk groups in Amsterdam, 2000-2002. J. Infect. Dis. 2004, 189:471-482.
221. Vaughan, G., Forbi, J.C., Xia, G., Fonseca-Ford, M., Vazquez, R., Khudyakov, Y.E., Montiel, S., Waterman, S., Alpuche, C., Gonçalves Rossi, L.M., Luna, N., (in press). Full-length genome characterization and genetic relatedness analysis of hepatitis A virus outbreak strains associated with acute liver failure among children. J Med Virol Accepted.
222. Vaughan, G., Xia, G., Forbi, J.C., Purdy, M.A., Gonçalves Rossi, L.M., Spradling, P., Khudyakov, Y.E., 2013b. Genetic Relatedness among Hepatitis A Virus Strains Associated with Food-borne Outbreaks. PLoS One Accepted.
223. Venkatramana M., Ray P.S., Chadda A., Das S. A 25 kDa cleavage product of polypyrimidine tract binding protein (PTB) present in mouse tissues prevents PTB binding to the 5' untranslated region and inhibits translation of hepatitis A virus RNA. Virus Res. 2003, 98:141-149.
224. Vento S., Garofano T., Di Perri G., Dolci L., Concia E., Bassetti D. Identification of hepatitis A virus as a trigger for autoimmune chronic hepatitis type 1 in susceptible individuals. Lancet 1991, 337:1183-1187.
225. Vento S., McFarlane B.M., McSorley C.G., Ranieri S., Giuliani-Piccari G., Dal Monte P.R., Verucchi G., Williams R., Chiodo F., McFarlane I.G. Liver autoreactivity in acute virus A, B and non-A, non-B hepatitis. J. Clin. Lab. Immunol. 1988, 25:1-7.
226. Victor J.C., Monto A.S., Surdina T.Y., Suleimenova S.Z., Vaughan G., Nainan O.V., Favorov M.O., Margolis H.S., Bell B.P. Hepatitis A vaccine versus immune globulin for postexposure prophylaxis. N. Engl. J. Med. 2007, 357:1685-1694.
227. Vidal A.E., Boiteux S., Hickson I.D., Radicella J.P. XRCC1 coordinates the initial and late stages of DNA abasic site repair through protein-protein interactions. EMBO J. 2001, 20:6530-6539.
228. Villar L.M., de Paula V.S., Diniz-Mendes L., Guimaraes F.R., Ferreira F.F., Shubo T.C., Miagostovich M.P., Lampe E., Gaspar A.M. Molecular detection of hepatitis A virus in urban sewage in Rio de Janeiro, Brazil. Lett. Appl. Microbiol. 2007, 45:168-173.
229. Villar L.M., de Paula V.S., Diniz-Mendes L., Guimarães F.R., Ferreira F.F., Shubo T.C., Miagostovich M.P., Lampe E., Gaspar A.M. Molecular detection of hepatitis A virus in urban sewage in Rio de Janeiro, Brazil. Lett. Appl. Microbiol. 2007, 45:168-173.
230. Villar L.M., Lampe E., Meyer A., Gaspar A.M. Genetic variability of hepatitis A virus isolates in Rio de Janeiro: implications for the vaccination of school children. Braz. J. Med. Biol. Res. 2004, 37:1779-1787.
231. Vong S., Fiore A.E., Haight D.O., Li J., Borgsmiller N., Kuhnert W., Pinero F., Boaz K., Badsgard T., Mancini C., Nainan O.V., Wiersma S., Bell B.P. Vaccination in the county jail as a strategy to reach high risk adults during a community-based hepatitis A outbreak among methamphetamine drug users. Vaccine 2005, 23:1021-1028.
232. Wang N., Liang Y., Devaraj S., Wang J., Lemon S.M., Li K. Toll-like receptor 3 mediates establishment of an antiviral state against hepatitis C virus in hepatoma cells. J. Virol. 2009, 83:9824-9834.
233. Wasley A., Fiore A., Bell B.P. Hepatitis A in the era of vaccination. Epidemiol. Rev. 2006, 28:101-111.
234. Wasley A., Flore A., Bell B.P. Hepatitis A in the era of vaccination. Epidemiol. Rev. 2006, 28:101-111.
235. Wheeler C., Vogt T.M., Armstrong G.L., Vaughan G., Weltman A., Nainan O.V., Dato V., Xia G., Waller K., Amon J., Lee T.M., Highbaugh-Battle A., Hembree C., Evenson S., Ruta M.A., Williams I.T., Fiore A.E., Bell B.P. An outbreak of hepatitis A associated with green onions. N. Engl. J. Med. 2005, 353:890-897.
236. Whetter L.E., Day S.P., Elroy-Stein O., Brown E.A., Lemon S.M. Low efficiency of the 5' non-translated region of hepatitis A virus RNA in directing cap-independent translation in permissive monkey kidney cells. J. Virol. 1994, 68.
237. Willner I.R., Uhl M.D., Howard S.C., Williams E.Q., Riely C.A., Waters B. Serious hepatitis A: an analysis of patients hospitalized during an urban epidemic in the United States. Ann. Intern. Med. 1998, 128:111-114.
238. World Health Organization Hepatitis A vaccines. Wkly. Epidemiol. Rec. 2000, 75:38-44.
239. Yang L., Kiyohara T., Kanda T., Imazeki F., Fujiwara K., Gauss-Muller V., Ishii K., Wakita T., Yokosuka O. Inhibitory effects on HAV IRES-mediated translation and replication by a combination of amantadine and interferon-alpha. Virol. J. 2010, 7:212.
240. Yang Y., Liang Y., Qu L., Chen Z., Yi M., Li K., Lemon S.M. Disruption of innate immunity due to mitochondrial targeting of a picornaviral protease precursor. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:7253-7258.
241. Yoneyama M., Kikuchi M., Natsukawa T., Shinobu N., Imaizumi T., Miyagishi M., Taira K., Akira S., Fujita T. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 2004, 5:730-737.
242. Yun H., Lee H.J., Jang J.H., Kim J.S., Lee S.H., Kim J.W., Park S.J., Park Y.M., Hwang S.G., Rim K.S., Kang S.K., Lee H.S., Jeong S.H. Hepatitis A virus genotype and its correlation with the clinical outcome of acute hepatitis A in Korea: 2006-2008. J. Med. Virol. 2011, 83:2073-2081.
243. Zhang B., Morace G., Gauss-Muller V., Kusov Y. Poly(A) binding protein, C-terminally truncated by the hepatitis A virus proteinase 3C, inhibits viral translation. Nucleic Acids Res. 2007, 35:5975-5984.
244. Zhang L., Yesupriya A., Hu D.J., Chang M.H., Dowling N.F., Ned R.M., Udhayakumar V., Lindegren M.L., Khudyakov Y. Variants in ABCB1, TGFB1, and XRCC1 genes and susceptibility to viral hepatitis A infection in Mexican Americans. Hepatology 2012, 55:1008-1018.
245. Zhang Y., Liu Y., Liu W., Zhou J., Chen H., Wang Y., Ma L., Ding Y., Zhang J. Analysis of synonymous codon usage in hepatitis A virus. Virol. J. 2011, 8:174.